#L5_Mechanism	L5_rn_lca	L4_family	L4_rn_lca	L3_subfamily	L3_rn_lca	L2_GeneType	L2_rn_lca	L1_GeneST	L1_rn_lca	HitRN_all	HitRN_all_adjust	HitRN_lca_exact	HitRN_all_exact	Discrete_block_n	Coverage	Coverage_ratio	CoverDepth	Varation	model_type	taxon_name	Effective_enzyme_inhibitors	gene_coded	aro_des	AMR_Gene_Family	AMR_Gene_Family_des	Antibiotic	Drug_Class	Adjuvant	Efflux_Component	Efflux_Regulator	Resistance_Mechanism	Resistance_Mechanism_des
Aminoglycoside-resistant_16S_ribosomal_subunit_protein	1194	A16S	1194	A16S	1194	Escherichia coli 16S rRNA (rrsH) mutation conferring resistance to spectinomycin	0	Escherichia coli 16S rRNA (rrsH) mutation conferring resistance to spectinomycin__1	0	819	601.040	0	267	6	1037/1391/1542	0.902	42.43	66(A->G),80.5(G),88(T),92(T->C),93(T->G),95(C->G),103(T->C),199(A->T),218(T->A),408(A->G),426(T->C),434(T->C),454.5(C),457(G),461(A->G),467.5(A),473(T->G),476(T),477(C->G),826(C->T),874(G->A),1244(G->A),1245(C->T),1292(G->A),1293(C->T),1355(G->A),1367(C->T)	rRNA gene variant model	Escherichia coli|Escherichia coli K-12|Escherichia sp.	-	chromosome	Point mutations in the 3' major domain of the rrsH 16S rRNA gene of Escherichia coli can confer resistance to spectinomycin	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	Point mutations in the 16S rRNA of bacteria can confer resistance to aminoglycosides.	spectinomycin	aminoglycoside_antibiotic;fluoroquinolone_antibiotic	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Fluoroquinolone-resistant_DNA_gyrase	874	GYRB	277	KP_GYRB	277	KP_gyrB	277	KPN_gyrB_ST2_2418_590__1	277	293	293.000	179	193	1	2204/2418/2418	1.000	8.79	633(T->C),879(C->T),909(C->T),1095(C->T),1167(C->T),1182(C->T),1569(T->C),1908(A->C),2349(C->T)	protein variant model	Klebsiella pneumoniae	-	-	-	fluoroquinolone resistant gyrB	-	-	carbapenem;fluoroquinolone_antibiotic;monobactam;triclosan	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Fluoroquinolone-resistant_DNA_gyrase	874	GYRA	227	KP_GYRA	223	KP_gyrA	223	KPN_gyrA_ST10_2634_37__1	223	227	227.000	145	146	1	2258/2634/2634	1.000	6.31	247(T->A),248(C->T),260(A->G),537(C->G),552(G->A),699(C->T),1167(C->T),1251(T->C),1533(C->T),1851(G->A),2502(A->G),2556(C->T),2568(A->G),2580(T->C)	protein variant model	Klebsiella pneumoniae	-	-	-	fluoroquinolone resistant gyrA	-	-	carbapenem;fluoroquinolone_antibiotic;monobactam;triclosan	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Fluoroquinolone-resistant_DNA_gyrase	874	PARC	218	KP_PARC	218	KP_parC	218	KPN_parC_ST5_2259_68__1	218	218	218.000	148	148	1	2014/2259/2259	1.000	7.14	239(G->T),726(C->T),765(C->T),840(T->G),1245(G->A),1854(G->T)	protein variant model	Klebsiella pneumoniae	-	-	-	fluoroquinolone resistant parC	-	-	carbapenem;fluoroquinolone_antibiotic;monobactam;triclosan	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Fluoroquinolone-resistant_DNA_gyrase	874	PARE	156	KP_PARE	156	KP_parE	156	KPN_parE_ST1_1896_1134__1	156	156	156.000	125	125	1	1875/1896/1896	1.000	6.04	0	protein variant model	Klebsiella pneumoniae	-	-	-	fluoroquinolone resistant parE	-	-	carbapenem;fluoroquinolone_antibiotic;monobactam;triclosan	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Class_A_betalactamases	474	KPC	235	KPC	235	KPC-2	0	KPC-2__1	0	234	234.000	0	188	1	882/882/882	1.000	19.04	0	protein homolog model	Achromobacter sp. AONIH1|Acinetobacter baumannii|Acinetobacter sp. ACNIH2|Aeromonas caviae|Aeromonas hydrophila|Aeromonas media|Aeromonas sp. ASNIH1|Aeromonas sp. ASNIH2|Aeromonas sp. ASNIH3|Aeromonas sp. ASNIH4|Aeromonas sp. ASNIH5|Aeromonas sp. ASNIH7|Aeromonas taiwanensis|Citrobacter braakii|Citrobacter farmeri|Citrobacter freundii|Citrobacter freundii complex sp. CFNIH3|Citrobacter freundii complex sp. CFNIH4|Citrobacter freundii complex sp. CFNIH9|Citrobacter portucalensis|Citrobacter sp.|Citrobacter sp. CFNIH10|Enterobacter cloacae|Enterobacter cloacae complex sp. ECNIH7|Enterobacter hormaechei|Enterobacter kobei|Enterobacteriaceae bacterium|Enterobacteriaceae bacterium ENNIH1|Enterobacteriaceae bacterium ENNIH2|Enterobacteriaceae bacterium ENNIH3|Escherichia coli|Klebsiella aerogenes|Klebsiella grimontii|Klebsiella michiganensis|Klebsiella oxytoca|Klebsiella pneumoniae|Klebsiella quasipneumoniae|Klebsiella variicola|Leclercia sp. LSNIH1|Leclercia sp. LSNIH3|Morganella morganii|Proteus mirabilis|Pseudomonas aeruginosa|Pseudomonas putida|Pseudomonas sp. PONIH3|Raoultella ornithinolytica|Salmonella enterica|Serratia marcescens|Serratia sp. SSNIH1|Stenotrophomonas maltophilia	-	chromosome;plasmid	KPC-2 is a beta-lactamase found in Klebsiella pneumoniae and Pseudomonas aeruginosa.	KPC beta-lactamase	Klebsiella pneumoniae carbapenem resistant (KPC) beta-lactamases are notorious for their ability to efficiently hydrolyze carbapenems, unlike other Ambler Class A beta-lactamases.  There are currently 9 variants reported worldwide.  These enzymes were first isolated from Klebsiella pneumoniae strains in 2001 in the United States.  Hospital outbreaks have since been reported in Greece and Israel and KPC carrying strains are now endemic to New York facilities.  KPC-1 and KPC-2 have been shown to be identical and are now referred to as KPC-2.	NA	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	NA	NA	NA	antibiotic inactivation	Enzymatic inactivation of antibiotic to confer drug resistance.
Class_A_betalactamases	474	KPC	235	KPC	235	KPC-25	0	KPC-25__2	0	223	223.000	0	177	1	888/888/888	1.000	17.95	0	protein homolog model	Achromobacter sp. AONIH1|Acinetobacter baumannii|Acinetobacter sp. ACNIH2|Aeromonas caviae|Aeromonas hydrophila|Aeromonas media|Aeromonas sp. ASNIH1|Aeromonas sp. ASNIH2|Aeromonas sp. ASNIH3|Aeromonas sp. ASNIH4|Aeromonas sp. ASNIH5|Aeromonas sp. ASNIH7|Aeromonas taiwanensis|Citrobacter braakii|Citrobacter farmeri|Citrobacter freundii|Citrobacter freundii complex sp. CFNIH3|Citrobacter freundii complex sp. CFNIH4|Citrobacter freundii complex sp. CFNIH9|Citrobacter portucalensis|Citrobacter sp.|Citrobacter sp. CFNIH10|Enterobacter cloacae|Enterobacter cloacae complex sp. ECNIH7|Enterobacter hormaechei|Enterobacter kobei|Enterobacteriaceae bacterium|Enterobacteriaceae bacterium ENNIH1|Enterobacteriaceae bacterium ENNIH2|Enterobacteriaceae bacterium ENNIH3|Escherichia coli|Klebsiella aerogenes|Klebsiella grimontii|Klebsiella michiganensis|Klebsiella oxytoca|Klebsiella pneumoniae|Klebsiella quasipneumoniae|Klebsiella variicola|Leclercia sp. LSNIH1|Leclercia sp. LSNIH3|Morganella morganii|Proteus mirabilis|Pseudomonas aeruginosa|Pseudomonas putida|Pseudomonas sp. PONIH3|Raoultella ornithinolytica|Salmonella enterica|Serratia marcescens|Serratia sp. SSNIH1|Stenotrophomonas maltophilia	-	plasmid	Carbapenem-hydrolyzing class A beta-lactamase kpc-25 [Klebsiella pneumoniae] Accession: WP_065419571.1	KPC beta-lactamase	Klebsiella pneumoniae carbapenem resistant (KPC) beta-lactamases are notorious for their ability to efficiently hydrolyze carbapenems, unlike other Ambler Class A beta-lactamases.  There are currently 9 variants reported worldwide.  These enzymes were first isolated from Klebsiella pneumoniae strains in 2001 in the United States.  Hospital outbreaks have since been reported in Greece and Israel and KPC carrying strains are now endemic to New York facilities.  KPC-1 and KPC-2 have been shown to be identical and are now referred to as KPC-2.	NA	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	NA	NA	NA	antibiotic inactivation	Enzymatic inactivation of antibiotic to confer drug resistance.
Class_A_betalactamases	474	SHV	218	SHV	218	SHV-12	0	SHV-12__2	0	203	203.000	0	158	1	861/861/861	1.000	17.22	0	protein homolog model	Acinetobacter baumannii|Acinetobacter junii|Acinetobacter sp.|Aeromonas caviae|Aeromonas hydrophila|Aeromonas sp. pRIVM0001_VIM-1|Aeromonas veronii|Brachymonas chironomi|Citrobacter farmeri|Citrobacter freundii|Citrobacter freundii complex sp. CFNIH9|Citrobacter sp. CF971|Cronobacter sakazakii|Enterobacter asburiae|Enterobacter cloacae|Enterobacter hormaechei|Enterobacter kobei|Enterobacteriaceae bacterium ENNIH1|Enterobacteriaceae bacterium ENNIH2|Escherichia coli|Escherichia fergusonii|Escherichia virus P1|Klebsiella aerogenes|Klebsiella michiganensis|Klebsiella oxytoca|Klebsiella pneumoniae|Klebsiella quasipneumoniae|Klebsiella variicola|Kluyvera cryocrescens|Leclercia adecarboxylata|Leclercia sp.|Leclercia sp. LSNIH1|Leclercia sp. LSNIH3|Pseudomonas aeruginosa|Pseudomonas sp. PONIH3|Raoultella ornithinolytica|Raoultella planticola|Raoultella terrigena|Salmonella enterica|Serratia sp. SSNIH1|Shewanella bicestrii|Shigella dysenteriae|Shigella flexneri|Shigella sp.	-	chromosome;plasmid	SHV-12 is an extended-spectrum beta-lactamase found in Acinetobacter baumannii.	SHV beta-lactamase	SHV-1 shares 68 percent of its amino acids with TEM-1 and has a similar overall structure. The SHV-1 beta-lactamase is most commonly found in K. pneumoniae and is responsible for up to 20% of the plasmid-mediated ampicillin resistance in this species. ESBLs in this family also have amino acid changes around the active site, most commonly at positions 238 or 238 and 240. More than 60 SHV varieties are known.	ceftazidime;ceftriaxone;cefalotin	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	NA	NA	NA	antibiotic inactivation	Enzymatic inactivation of antibiotic to confer drug resistance.
Colistin_phosphoethanolamine_transferase	394	EPTB	238	EPTB	238	eptB	238	eptB__1	238	238	238.000	155	155	1	1443/1725/1725	1.000	10.10	360(T->C),437(T->C),693(A->T),851(A->G),917(T->C),987(C->A)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella pneumoniae subsp. rhinoscleromatis SB3432	-	plasmid	eptB is a phosphoethanolamine transferase. It confers resistance to peptide antibiotics.	pmr phosphoethanolamine transferase	This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.	NA	macrolide_antibiotic;peptide_antibiotic	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Colistin_phosphoethanolamine_transferase	394	ARNT	156	ARNT	156	ArnT	156	ArnT__1	156	156	150.908	116	116	2	1601/1637/1656	0.989	7.00	347(T->C),458(T->C),591(C->T)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae	-	plasmid	ArnT is involved in Cell Wall Biosynthesis, specifically 4-amino-4-deoxy-L-arabinose (Ara4N). It confers resistance to peptide antibiotics.	pmr phosphoethanolamine transferase	This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.	NA	macrolide_antibiotic;peptide_antibiotic	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Multi-drug_ABC_efflux_pumps	269	LPTD	269	LPTD	269	LptD	269	LptD__1	269	269	269.000	227	227	1	2349/2349/2349	1.000	8.38	0	protein homolog model	Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae KPNIH10	-	chromosome	LptD is involved in LPS transport in a ABC Transporter efflux system. It confers resistance to carbapenems, rifamycin, aminocoumarin and peptide antibiotics.	ATP-binding cassette (ABC) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.	NA	Aldehydes;Aminocoumarins;Heat;Lipopeptides;Peroxides;Phenicol;Rifampin;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;glycylcycline;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitroimidazole_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;pleuromutilin_antibiotic;rifamycin_antibiotic;streptogramin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	NA	antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Mutant_porin_proteins	264	OMPA	100	OMPA	100	OmpA	100	OmpA__1	100	100	100.000	69	69	1	1080/1125/1125	1.000	6.43	91(G->A),252(C->T),995(C->A)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae	-	chromosome	OmpA is a porin that confers resistance to beta-lactam antibiotics.	General Bacterial Porin with reduced permeability to beta-lactams	These are GBPs that are associated with decreased susceptibility to beta-lactams either through mutations in the porin protein, absence of the porin protein, or expression of the porin protein.	NA	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	NA	NA	NA	reduced permeability to antibiotic	Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.
Mutant_porin_proteins	264	OMP37	91	OMP37	91	Klebsiella pneumoniae OmpK37	91	Klebsiella pneumoniae OmpK37__1	91	91	81.015	45	45	3	818/1082/1125	0.962	5.70	210(T->G),384(T->G),477(T->C),624(T->C),648(C->T),723(T->C),732(A->C),804(T->G),843(A->G)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella quasivariicola|Klebsiella sp. P1CD1|Klebsiella sp. PO552|Klebsiella variicola	-	chromosome;plasmid	Klebsiella pneumoniae outer membrane porin protein. Is preferentially detected in porin-deficient strains. Functional characterization of this new porin revealed a narrower pore than those of porins OmpK35 and OmpK36, which did not allow penetration by certain beta-lactams. Also, when a resistant strain expresses porin OmpK37 is less susceptible to cefotaxime and cefoxitin than when it is expressing either OmpK36 or OmpK35.	General Bacterial Porin with reduced permeability to beta-lactams	These are GBPs that are associated with decreased susceptibility to beta-lactams either through mutations in the porin protein, absence of the porin protein, or expression of the porin protein.	cefoxitin;cefotaxime	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	NA	NA	NA	reduced permeability to antibiotic	Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.
Mutant_porin_proteins	264	OMPK	67	OMPK	67	Klebsiella pneumoniae OmpK35	67	Klebsiella pneumoniae OmpK35__1	67	67	63.060	53	53	2	660/670/684	0.980	7.15	0	protein knockout model	Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae HS11286	-	transposon	Klebsiella pneumoniae outer membrane porin protein. In beta-lactam-resistant Klebsiella, this porin is often deleted, limiting diffusion of the antibiotic into the cell. Klebsiella strains expressing OmpK35 are often beta-lactam sensitive even in the presence of beta-lactamases because of an inefficient mechanism.	General Bacterial Porin with reduced permeability to beta-lactams	These are GBPs that are associated with decreased susceptibility to beta-lactams either through mutations in the porin protein, absence of the porin protein, or expression of the porin protein.	NA	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	NA	NA	NA	reduced permeability to antibiotic;resistance by absence	Mechanism of antibiotic resistance conferred by deletion of gene (usually a porin)
Rifampicin/Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB	250	RPOB	250	RPOB	250	Escherichia coli rpoB mutants conferring resistance to rifampicin	250	Escherichia coli rpoB mutants conferring resistance to rifampicin__1	250	250	103.373	18	18	10	470/3003/4029	0.745	6.16	72(A->G),75(T->A),105(T->C),111(A->G),222(C->T),225(T->G),237(G->T),246(C->T),247(C->A),249(G->A),258(A->G),315(T->C),330(G->A),342(A->C),393(A->C),423(T->C),441(C->T),924(G->A),934(G->C),936(A->G),954(C->T),987(T->C),1017(T->C),1026(T->C),1038(T->C),1050(C->G),1051(T->G),1056(T->C),1065(A->G),1074(C->T),1086(A->G),1105(A->G),1140(A->C),1143(G->T),1149(C->T),1155(C->T),1173(C->T),1182(T->C),1185(T->C),1188(C->T),1194(T->C),1236(A->C),1251(T->C),1278(T->C),1281(T->A),1284(T->G),1290(A->G),1326(C->G),1329(T->C),1443(G->T),1518(C->T),1623(A->G),1626(T->C),1659(T->C),1680(A->G),1689(C->G),1767(T->G),1785(T->C),1786(G->A),1794(T->G),1797(A->T),1851(C->T),1876(G->A),1878(A->C),1896(C->T),1902(A->T),1941(T->C),2067(C->G),2082(T->C),2106(T->C),2142(A->T),2148(G->C),2151(T->G),2163(T->C),2167(G->A),2168(T->C),2226(T->C),2232(T->C),2253(C->T),2388(T->G),2403(C->T),2424(T->C),2454(A->T),2541(A->G),2559(C->T),2589(C->T),2601(A->G),2619(T->C),2688(C->G),2691(A->G),2697(A->G),2709(T->C),2763(A->G),2772(A->C),2775(C->T),2781(G->C),2835(G->T),2850(A->G),2859(C->G),2862(A->G),2868(G->C),2871(G->A),2907(G->C),2919(C->T),2931(T->G),2940(A->C),2941(G->T),2973(A->G),2974(T->C),2979(G->T),2997(G->A),3081(G->A),3102(C->T),3114(G->A),3153(G->T),3165(G->C),3192(C->T),3201(A->G),3225(A->T),3228(T->C),3258(T->G),3259(T->C),3266(A->C),3267(A->T),3285(C->T),3339(C->T),3345(C->T),3349(T->C),3363(G->A),3369(T->C),3378(C->T),3426(T->C),3621(T->C),3631(C->A),3632(G->C),3638(A->T),3639(C->T),3642(C->T),3651(T->C),3681(T->G),3726(G->A),3735(G->T),3807(T->C),3813(G->T),3849(A->G),3852(A->C),3906(T->C),3936(C->T),3939(T->C),3948(G->A),3960(A->G),3976(T->C)	protein variant model	Escherichia coli|Escherichia coli O157:H7 str. Sakai|Escherichia sp. SCLE84|Shigella sp. PAMC 28760	-	chromosome	Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	Rifampin resistant RNA polymerases include amino acids substitutions which disrupt the affinity of rifampin for its binding site. These mutations are frequently concentrated in the rif I region of the beta-subunit and most often involve amino acids which make direct interactions with rifampin. However, mutations which also confer resistance can occur outside this region and may involve amino acids which do not directly make contact with rifampin.	rifampin;rifaximin;rifabutin;rifapentine	Aldehydes;Aminocoumarins;Heat;Lipopeptides;Peroxides;Phenicol;Rifampin;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;glycylcycline;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitroimidazole_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;pleuromutilin_antibiotic;rifamycin_antibiotic;streptogramin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	NA	NA	antibiotic target alteration;antibiotic target replacement	Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.
EF-Tu_inhibition	249	TUFAB	249	TUFAB	249	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa	25	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa__1	0	476	457.676	0	76	2	438/1170/1185	0.987	14.81	15(A->G),39(T->C),69(C->T),81(T->C),87(C->T),93(A->C),99(C->T),123(C->T),127(G->T),129(T->C),135(T->C),190(A->G),195(T->C),210(C->T),252(G->C),291(T->G),315(A->T),453(A->G),471(T->G),486(C->T),504(T->C),568(C->A),570(G->C),583(T->C),584(T->A),592(T->A),594(T->C),600(T->C),699(A->G),717(T->A),750(G->A),753(T->C),754(C->G),755(A->C),759(G->A),760(T->A),762(T->C),900(G->C),933(T->C),945(T->C),960(T->C),1020(T->C),1167(T->A)	protein variant model	Escherichia coli|Escherichia coli str. K-12 substr. MG1655|Escherichia sp. SCLE84|Salmonella sp. HNK130|Shigella flexneri|Shigella sonnei	-	chromosome	Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Enacyloxin IIa	elfamycin resistant EF-Tu	Sequence variants of elongation factor Tu that confer resistance to elfamycin antibiotics.	enacyloxin IIa	elfamycin_antibiotic	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Drug_and_biocide_MFS_efflux_pumps	249	KPNH	138	KPNH	138	Klebsiella pneumoniae KpnH	138	Klebsiella pneumoniae KpnH__1	138	138	138.000	92	92	1	1494/1539/1539	1.000	6.45	1290(G->A)	protein homolog model	Klebsiella pneumoniae UHKPC23	-	plasmid	KpnH consists of ~511 residues, resembles EmrB of E. coli, and is probably a translocase in the KpnGH-TolC efflux protein in K. pneumoniae. Disruption of the pump components KpnG-KpnH signficantly decrease resistance to azithromycin, ceftazidime, ciprofloxacin, ertapenem, erythromycin, gentamicin, imipenem, ticarcillin, norfloxacin, polymyxin-B, piperacillin, spectinomycin, tobramycin, and streptomycin.	major facilitator superfamily (MFS) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.	erythromycin;gentamicin C;ciprofloxacin;spectinomycin;streptomycin;tobramycin;ceftazidime;ertapenem;piperacillin;azithromycin;imipenem;polymyxin B1;polymyxin B2;polymyxin B3;polymyxin B4;norfloxacin;ticarcillin	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	NA	antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Drug_and_biocide_MFS_efflux_pumps	249	KPN	107	KPN	107	Klebsiella pneumoniae KpnG	107	Klebsiella pneumoniae KpnG__1	107	107	107.000	64	64	1	1073/1173/1173	1.000	6.60	409(T->G),885(T->C),903(C->T),924(C->T),954(C->T),1110(C->T)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella sp. 4_1_44FAA	-	chromosome	KpnG consists of ~390 residues and resembles EmrA of E. coli. Disruption of the pump components KpnG-KpnH signficantly decrease resistance to azithromycin, ceftazidime, ciprofloxacin, ertapenem, erythromycin, gentamicin, imipenem, ticarcillin, norfloxacin, polymyxin-B, piperacillin, spectinomycin, tobramycin, and streptomycin	major facilitator superfamily (MFS) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.	erythromycin;gentamicin C;ciprofloxacin;spectinomycin;streptomycin;tobramycin;ceftazidime;ertapenem;piperacillin;azithromycin;imipenem;polymyxin B1;polymyxin B2;polymyxin B3;polymyxin B4;norfloxacin;ticarcillin	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	NA	antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Chloramphenicol_acetyltransferases	218	CATA	218	CATA	218	catII from Escherichia coli K-12	194	catII from Escherichia coli K-12__1	194	196	196.000	2	2	1	39/642/642	1.000	21.47	48(C->T),123(C->T),133(G->A),135(G->A),138(A->C),214(C->A),222(C->T),231(T->G),243(C->A),294(T->C),339(A->G),348(T->C),357(G->A),381(A->G),429(A->G),435(G->C),459(C->T),465(C->T),490(G->T),504(G->A),538(T->C),573(A->C),582(C->T),595(C->A),603(T->C)	protein homolog model	Aeromonas hydrophila|Aeromonas salmonicida|Citrobacter farmeri|Citrobacter freundii|Citrobacter freundii complex sp. CFNIH9|Citrobacter sp. S39|Citrobacter werkmanii|Cronobacter sakazakii|Edwardsiella anguillarum|Edwardsiella piscicida|Enterobacter cloacae|Enterobacter hormaechei|Enterobacter kobei|Enterobacteriaceae bacterium|Escherichia coli|Escherichia coli K-12|Klebsiella aerogenes|Klebsiella huaxiensis|Klebsiella michiganensis|Klebsiella oxytoca|Klebsiella pneumoniae|Klebsiella quasipneumoniae|Klebsiella sp. LY|Klebsiella variicola|Legionella pneumophila|Morganella morganii|Photobacterium damselae|Phytobacter ursingii|Raoultella ornithinolytica|Rheinheimera sp. D18|Salmonella enterica|Salmonella sp.|Salmonella sp. TC67|Shewanella xiamenensis|Shigella flexneri|Vibrio cholerae|Vibrio parahaemolyticus|Yersinia pseudotuberculosis	-	chromosome;plasmid	catII is a chloramphenicol acetyltransferase. This particular catII is found in E.coli K-12. Confers resistance to chloramphenicol.	chloramphenicol acetyltransferase (CAT)	Inactivates chloramphenicol by addition of an acyl group. cat is used to describe many variants of the chloramphenicol acetyltransferase gene in a range of organisms including Acinetobacter calcoaceticus, Agrobacterium tumefaciens, Bacillus clausii, Bacillus subtilis, Campylobacter coli, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Listeria monocytogenes, Listonella anguillarum Morganella morganii, Photobacterium damselae subsp. piscicida, Proteus mirabilis, Salmonella typhi, Serratia marcescens, Shigella flexneri, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus intermedius, Streptococcus agalactiae, Streptococcus suis and Streptomyces acrimycini	chloramphenicol	phenicol_antibiotic	NA	NA	NA	antibiotic inactivation	Enzymatic inactivation of antibiotic to confer drug resistance.
16S_rRNA_methyltransferases	185	RMT	185	RMT	185	rmtB	185	rmtB__1	185	185	185.000	159	159	1	756/756/756	1.000	17.87	0	protein homolog model	Citrobacter freundii|Citrobacter koseri|Citrobacter sp. H12-3-2|Citrobacter sp. S40-1-2|Enterobacter cloacae|Enterobacter hormaechei|Escherichia coli|Escherichia fergusonii|Klebsiella aerogenes|Klebsiella pneumoniae|Proteus mirabilis|Providencia rettgeri|Providencia sp. WCHPHu000369|Pseudomonas aeruginosa|Salmonella enterica|Serratia marcescens	-	plasmid	RmtB is a 16S rRNA methyltransferase that targets mature or nearly mature 30S subunits. It transfers a methyl group from S-adenosyl-L-methionine to N7-G1405 of the 16S rRNA, an aminoglycoside binding site.	16S rRNA methyltransferase (G1405)	Methyltransferases that methylate the G1405 position of 16S rRNA, which is part of an aminoglycoside binding site.	dibekacin;amikacin;gentamicin C;sisomicin;netilmicin;kanamycin A;tobramycin;isepamicin;G418;arbekacin;gentamicin B	aminoglycoside_antibiotic;fluoroquinolone_antibiotic	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Fosfomycin_thiol_transferases	156	FOSA	156	FOSA	156	FosA3	119	FosA3__1	119	131	131.000	94	99	1	417/417/417	1.000	21.52	0	protein homolog model	Acinetobacter baumannii|Aeromonas veronii|Citrobacter freundii|Citrobacter sp. H12-3-2|Citrobacter sp. S39|Citrobacter sp. S40-1-2|Cronobacter sakazakii|Enterobacter cloacae|Enterobacter hormaechei|Escherichia coli|Escherichia fergusonii|Escherichia sp. SCLE84|Klebsiella aerogenes|Klebsiella huaxiensis|Klebsiella michiganensis|Klebsiella pneumoniae|Klebsiella variicola|Kluyvera georgiana|Kluyvera intermedia|Kluyvera sp. PO2S7|Proteus mirabilis|Raoultella ornithinolytica|Salmonella enterica|Salmonella sp. HNK130|Salmonella sp. SSDFZ54|Shigella flexneri	-	plasmid	An enzyme that confers resistance to fosfomycin in Escherichia coli by breaking the epoxide ring of the molecule. It depends on the cofactors Manganese (II) and Potassium and uses Glutathione (GSH) as the nucleophilic molecule.	fosfomycin thiol transferase	Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.	NA	fluoroquinolone_antibiotic;fosfomycin	NA	NA	NA	antibiotic inactivation	Enzymatic inactivation of antibiotic to confer drug resistance.
Fosfomycin_thiol_transferases	156	FOSA	156	FOSA	156	FosA6	9	FosA6__1	9	19	9.801	8	15	1	270/337/420	0.802	3.93	271(A->G)	protein homolog model	Escherichia coli|Klebsiella pneumoniae|Klebsiella sp. 4_1_44FAA	-	plasmid	fosA6 is a plasmid-encoded enzyme that confers resistance to fosfomycin in Escherichia coli by breaking the epoxide ring of the molecule.	fosfomycin thiol transferase	Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.	NA	fluoroquinolone_antibiotic;fosfomycin	NA	NA	NA	antibiotic inactivation	Enzymatic inactivation of antibiotic to confer drug resistance.
IS5-like_element_IS903B_family_transposase	144	IS903B_family_transposase	144	IS903B_family_transposase	144	WP7S18C02830	144	WP7S18C02830__1	144	144	85.655	70	70	3	528/792/942	0.841	12.39	315(C->T),326(G->C),328(T->A),338(G->A),358(A->G),373(C->T),402(A->G),429(C->T),441(G->A),443(G->A),486(T->A),490(C->T),621(C->A),624(T->C),627(A->C),636(T->C),637(A->C),723(A->T)	protein homolog model	Aeromonas caviae|Aeromonas hydrophila|Citrobacter freundii|Citrobacter sp. S39|Enterobacter asburiae|Enterobacter cloacae|Enterobacter hormaechei|Enterobacter roggenkampii|Escherichia coli|Klebsiella aerogenes|Klebsiella huaxiensis|Klebsiella michiganensis|Klebsiella oxytoca|Klebsiella pneumoniae|Klebsiella quasipneumoniae|Klebsiella sp. LY|Klebsiella variicola|Kluyvera intermedia|Proteus mirabilis|Providencia sp. WCHPHu000369|Raoultella ornithinolytica|Salmonella enterica|Salmonella sp. S13|Salmonella virus SJ46|Serratia marcescens|Shigella boydii|Shigella sonnei|Vibrio parahaemolyticus	-	chromosome;plasmid;transposon	-	-	-	-	carbapenem;cephalosporin;cephamycin;monobactam;penam;penem	-	-	-	-	-
Multi-drug_RND_efflux_regulator	132	RAMA	85	RAMA	85	E.coli ramA	85	E.coli ramA__1	85	85	85.000	19	19	1	350/621/621	1.000	9.64	135(A->G),192(C->G),195(T->C),228(C->T),324(T->C),336(A->T),345(T->C),360(T->C),366(A->G),413(G->A),414(T->A),415(C->G),429(A->C),450(G->A),456(G->A),546(T->C),553(A->C)	protein variant model	Escherichia coli str. K-12 substr. MG1655	-	chromosome;plasmid	-	-	-	-	peptide antibiotic	-	-	-	-	-
Multi-drug_RND_efflux_regulator	132	RAMR	47	RAMR	47	Klebsiella pneumoniae ramR mutants	47	Klebsiella pneumoniae ramR mutants__1	47	47	46.299	35	35	1	568/579/582	0.995	5.75	0	protein variant model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae MGH 78578	-	chromosome;plasmid	RamR is a repressor that regulates RamA expression. Mutations lead to the upregulation of AcrAB, which is positively regulated by RamA.	resistance-nodulation-cell division (RND) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.	tigecycline;tetracycline;rifampin;chloramphenicol;ampicillin;cefalotin	Aldehydes;Aminocoumarins;Heat;Lipopeptides;Peroxides;Phenicol;Rifampin;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;glycylcycline;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitroimidazole_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;pleuromutilin_antibiotic;rifamycin_antibiotic;streptogramin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	protein(s) and two-component regulatory system modulating antibiotic efflux	antibiotic target alteration;antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Fosfomycin_target_mutation	118	PTSL	71	PTSL	71	Escherichia coli PtsI with mutation conferring resistance to fosfomycin	71	Escherichia coli PtsI with mutation conferring resistance to fosfomycin__1	71	71	14.582	6	6	6	164/1019/1728	0.590	4.87	36(T->C),42(T->C),48(T->A),49(C->T),54(T->G),60(A->G),66(C->T),240(C->G),255(G->T),297(A->T),300(T->C),306(A->G),309(T->A),312(T->C),313(C->A),327(A->C),336(T->C),337(T->A),426(G->T),429(C->T),433(A->G),434(A->C),435(G->A),438(T->C),444(C->T),993(T->C),1005(C->T),1029(A->G),1074(C->T),1077(T->C),1078(A->G),1080(C->G),1086(C->T),1100(G->A),1116(T->C),1120(C->G),1122(C->T),1128(T->C),1143(G->C),1155(A->G),1156(T->C),1203(A->G),1207(C->A),1208(G->A),1209(C->G),1242(C->T),1257(G->A),1266(G->A),1269(A->C),1275(A->G),1284(A->G),1305(C->G),1308(A->G),1311(A->T),1317(A->T),1324(T->C),1326(A->G),1374(G->A),1377(C->T),1416(C->T),1428(A->G),1440(C->T),1443(G->A),1449(C->T),1450(T->C),1455(C->T),1479(T->C),1488(C->T),1506(T->C),1518(T->G),1551(G->T),1557(T->G),1587(T->C),1599(T->C),1611(C->T),1617(C->T),1638(G->A),1641(G->A)	protein variant model	Escherichia coli|Escherichia coli str. K-12 substr. MC4100|Salmonella sp. HNK130|Salmonella sp. S13|Shigella boydii|Shigella sp. PAMC 28760	-	chromosome	PtsI (phosphoenolpyruvate-protein phosphotransferase) is involved in cyclic AMP synthesis, which regulates glpT expression. As a result, mutations to ptsI confer resistance to fosfomycin by affecting the regulation of fosfomycin import.	antibiotic-resistant ptsI phosphotransferase	PtsI family phosphotransferases are involved in cyclic AMP synthesis, which regulates glpT expression. Mutations in PtsI family genes can negatively affect expression of UhpT, which is needed for fosfomycin import.	NA	fluoroquinolone_antibiotic;fosfomycin	NA	NA	NA	antibiotic target alteration	Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.
Drug_and_biocide_RND_efflux_pumps	114	ADEI	92	ADEI	92	Klebsiella pneumoniae acrA	92	Klebsiella pneumoniae acrA__1	92	92	64.639	39	39	2	623/1064/1197	0.889	6.28	275(T->C),306(A->G),308(G->C),406(C->A),433(C->A),610(T->C),627(A->G),628(G->C),701(C->G),741(G->A),756(G->T),867(T->A),984(T->G)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae	-	chromosome	AcrA is a subunit of the AcrAB multidrug efflux system that in K. pneumoniae, which is encoded by the acrRAB operon.	resistance-nodulation-cell division (RND) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.	tigecycline;tetracycline;rifampin;chloramphenicol;ampicillin;cefalotin	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	NA	antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Drug_and_biocide_SMR_efflux_pumps	114	KPNO	64	KPNO	64	Klebsiella pneumoniae OmpK36	62	Klebsiella pneumoniae OmpK36__1	62	63	31.180	32	32	4	560/873/1104	0.791	4.92	546(C->T),547(G->A),550(CTG),558(T->G),609(T->C),654(A->G),660(T->G),661(A->C),891(G->A),918(T->C),919(C->A),921(G->C),927(C->T),943(A->C),945(C->G),1053(C->T)	protein knockout model	Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae HS11286	-	transposon	Klebsiella pneumoniae outer membrane porin protein. In beta-lactam-resistant Klebsiella, this porin is often deleted, limiting diffusion of the antibiotic into the cell. Klebsiella strains expressing OmpK36 are often beta-lactam sensitive even in the presence of beta-lactamases because of an inefficient mechanism.	General Bacterial Porin with reduced permeability to beta-lactams	These are GBPs that are associated with decreased susceptibility to beta-lactams either through mutations in the porin protein, absence of the porin protein, or expression of the porin protein.	NA	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	NA	NA	reduced permeability to antibiotic;resistance by absence	Mechanism of antibiotic resistance conferred by deletion of gene (usually a porin)
Drug_and_biocide_SMR_efflux_pumps	114	KPNE	33	KPNE	33	kpnE	33	kpnE__1	33	33	33.000	24	24	1	315/363/363	1.000	6.57	333(A->C),334(C->A)	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044	-	plasmid	KpnE subunit of KpnEF resembles EbrAB from E. coli. Mutation in KpnEF resulted in increased susceptibility to cefepime, ceftriaxon, colistin, erythromycin, rifampin, tetracycline, and streptomycin as well as enhanced sensitivity toward sodium dodecyl sulfate, deoxycholate, dyes, benzalkonium chloride, chlorhexidine, and triclosan	major facilitator superfamily (MFS) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.	erythromycin;streptomycin;tetracycline;cefepime;ceftriaxone;rifampin;colistin A;colistin B	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	NA	antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Drug_and_biocide_SMR_efflux_pumps	114	KPNF	17	KPNF	17	kpnF	17	kpnF__1	17	17	17.000	13	13	1	330/330/330	1.000	3.45	0	protein homolog model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044	-	plasmid	KpnF subunit of KpnEF resembles EbrAB from E. coli. Mutation in KpnEF resulted in increased susceptibility to cefepime, ceftriaxon, colistin, erythromycin, rifampin, tetracycline, and streptomycin as well as enhanced sensitivity toward sodium dodecyl sulfate, deoxycholate, dyes, benzalkonium chloride, chlorhexidine, and triclosan.	major facilitator superfamily (MFS) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.	erythromycin;streptomycin;tetracycline;cefepime;ceftriaxone;rifampin;colistin A;colistin B	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	NA	antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Drug_and_biocide_RND_efflux_regulator	100	ACRR	69	ACRR	69	Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance	69	Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance__1	69	69	69.000	48	48	1	621/651/651	1.000	7.60	441(G->A)	protein variant model	Klebsiella aerogenes|Klebsiella pneumoniae|Klebsiella pneumoniae subsp. pneumoniae MGH 78578	-	chromosome	AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance.	resistance-nodulation-cell division (RND) antibiotic efflux pump	Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.	tigecycline;tetracycline;rifampin;chloramphenicol;ampicillin;cefalotin	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	protein(s) and two-component regulatory system modulating antibiotic efflux	antibiotic target alteration;antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Drug_and_biocide_ABC_efflux_regulator	56	PHOB	56	PHOB	56	Klebsiella mutant PhoP conferring antibiotic resistance to colistin	56	Klebsiella mutant PhoP conferring antibiotic resistance to colistin__1	56	56	56.000	46	46	1	661/672/672	1.000	5.74	0	protein variant model	Klebsiella aerogenes|Klebsiella pneumoniae	-	chromosome	A mutant phoP activates pmrHFIJKLM expression responsible for L-aminoarabinose synthesis and polymyxin resistance, by way of alteration of negative charge	ATP-binding cassette (ABC) antibiotic efflux pump;pmr phosphoethanolamine transferase	This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.	erythromycin;colistin A;colistin B	Quaternary_Ammonium_Compounds;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;antibacterial_free_fatty_acids;benzalkonium_chloride;bicyclomycin;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;fosfomycin;glycylcycline;isoniazid;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitrofuran_antibiotic;nucleoside_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;rhodamine;rifamycin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	efflux pump complex or subunit conferring antibiotic resistance	protein(s) and two-component regulatory system modulating antibiotic efflux	antibiotic target alteration;antibiotic efflux	Antibiotic resistance via the transport of antibiotics out of the cell.
Multi-drug_resistance_Mutant_porin_proteins	4	LAMB	4	LAMB	4	Escherichia coli LamB	4	Escherichia coli LamB__1	4	4	0.001	2	2	1	34/81/1341	0.060	2.54	36(T->C),48(G->A),54(A->G),69(A->G),70(A->C),78(T->C)	protein knockout model	Escherichia coli|Escherichia coli O157:H7 str. Sakai|Escherichia sp. SCLE84|Shigella boydii|Shigella dysenteriae|Shigella flexneri|Shigella sonnei	-	chromosome	LamB is a negative regulator for antibiotic resistance, it serves as a porin to influx antibiotic. When down-regulated, it increases resistance to chlortetracycline, ciprofloxacin, balofloxacin and nalidixic acid. It also interacts with Odp1, an energy metabolic enzyme, creating a complex that decreases in antibiotic-resistant strains.	Sugar Porin (SP)	Members of the Sugar Porin family tend to facilitate the transport of maltodextrins and other sugars across the outer membrane of Gram-negative bacteria. These porins form a homotrimeric structure.	ciprofloxacin;chlortetracycline;nalidixic acid;balofloxacin	Aldehydes;Aminocoumarins;Heat;Lipopeptides;Peroxides;Phenicol;Rifampin;acridine_dye;aminocoumarin_antibiotic;aminoglycoside_antibiotic;carbapenem;cephalosporin;cephamycin;diaminopyrimidine_antibiotic;disinfecting_agents_and_intercalating_dyes;fluoroquinolone_antibiotic;glycylcycline;lincosamide_antibiotic;macrolide_antibiotic;monobactam;nitroimidazole_antibiotic;oxazolidinone_antibiotic;penam;penem;peptide_antibiotic;phenicol_antibiotic;pleuromutilin_antibiotic;rifamycin_antibiotic;streptogramin_antibiotic;sulfonamide_antibiotic;tetracycline_antibiotic;triclosan	NA	NA	NA	reduced permeability to antibiotic;resistance by absence	Mechanism of antibiotic resistance conferred by deletion of gene (usually a porin)
